These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11347972)

  • 1. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance.
    Lee MD; Galazzo JL; Staley AL; Lee JC; Warren MS; Fuernkranz H; Chamberland S; Lomovskaya O; Miller GH
    Farmaco; 2001; 56(1-2):81-5. PubMed ID: 11347972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerulenin analogues as inhibitors of efflux pumps in drug-resistant Candida albicans.
    Diwischek F; Morschhäuser J; Holzgrabe U
    Arch Pharm (Weinheim); 2009 Mar; 342(3):150-64. PubMed ID: 19253321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India.
    Choudhury D; Ghose A; Dhar Chanda D; Das Talukdar A; Dutta Choudhury M; Paul D; Maurya AP; Chakravarty A; Bhattacharjee A
    PLoS One; 2016; 11(2):e0149156. PubMed ID: 26866484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position.
    Yoshida K; Nakayama K; Kuru N; Kobayashi S; Ohtsuka M; Takemura M; Hoshino K; Kanda H; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem; 2006 Mar; 14(6):1993-2004. PubMed ID: 16290941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model.
    Nakayama K; Kawato H; Watanabe J; Ohtsuka M; Yoshida K; Yokomizo Y; Sakamoto A; Kuru N; Ohta T; Hoshino K; Yoshida K; Ishida H; Cho A; Palme MH; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem Lett; 2004 Jan; 14(2):475-9. PubMed ID: 14698185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors.
    Choudhury D; Talukdar AD; Chetia P; Bhattacharjee A; Choudhury MD
    Comb Chem High Throughput Screen; 2016; 19(9):705-713. PubMed ID: 27450181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
    De Kievit TR; Parkins MD; Gillis RJ; Srikumar R; Ceri H; Poole K; Iglewski BH; Storey DG
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1761-70. PubMed ID: 11353623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization.
    Nakayama K; Ishida Y; Ohtsuka M; Kawato H; Yoshida Ki; Yokomizo Y; Hosono S; Ohta T; Hoshino K; Ishida H; Yoshida K; Renau TE; Léger R; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4201-4. PubMed ID: 14623001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpxR Activates MexAB-OprM Efflux Pump Expression and Enhances Antibiotic Resistance in Both Laboratory and Clinical nalB-Type Isolates of Pseudomonas aeruginosa.
    Tian ZX; Yi XX; Cho A; O'Gara F; Wang YP
    PLoS Pathog; 2016 Oct; 12(10):e1005932. PubMed ID: 27736975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters.
    Picard M; Tikhonova EB; Broutin I; Lu S; Verchère A; Zgurskaya HI
    Methods Mol Biol; 2018; 1700():113-145. PubMed ID: 29177829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.